Sharon Mates - Intra Cellular Insider

Intra Cellular Therapies Inc -- USA Stock  

USD 15.98  0.1  0.62%

Co-Founder, Chairman, CEO and Pres

Dr. Sharon Mates, Ph.D., is Chairman of the Board, President, Chief Executive Officer of IntraCellular Therapies, Inc. Dr. Mates cofounded ITI in May 2002. Prior to cofounding ITI, Dr. Mates was a cofounder of Functional Genetics, and served as its Chairman and Chief Executive Officer from December 2000 until August 2003. From 19891998 Dr. Mates was the President and a board member of North American Vaccine Inc. and its predecessor companies. She has served on several boards, and recently completed a board membership and a twoyear chairmanship of the Board of the New York Biotechnology Association. Dr. Mates has also served on the Advisory Council of the Center for Society and Health at the Harvard School of Public Health, the Board of Visitors of the Biotechnology Institute of the University of Maryland and the board of directors of Gildas Club of New York. Earlier in her career, Dr. Mates spent several years as a research analyst and investment banker, and as an advisor to the life sciences industry
Age: 63  Chairman Since 2014  Ph.D    
212 923-3344  www.intracellulartherapies.com
Mates received her B.S. from the Ohio State University and her Ph.D. from the University of Washington, and completed her postdoctoral fellowships at The Massachusetts General Hospital and Harvard Medical School.

Management Efficiency

The company has return on total asset (ROA) of (16.4) % which means that it has lost $16.4 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (26.76) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Entity Summary

IntraCellular Therapies, Inc., a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system . Intra Cellular Therapies Inc (ITCI) is traded on NASDAQ in USA. It is located in NEW YORK, U.S.A and employs 37 people. Intra Cellular is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Intra Cellular Therapies Inc to your portfolio

Top Management

Intra Cellular Thera Leadership Team
Lawrence Wennogle, President, Ph.D
Christopher Alafi, Director
Michael Rawlins, Director
Robert Nostrand, Director
Richard Lerner, Director
Robert Davis, President, Ph.D
Allen Fienberg, Founder, Ph.D
Michael Halstead, SVP
Sharon Mates, Chairman, Ph.D
Juan Sanchez, President
Rory Riggs, Director, MBA
Joel Marcus, Director
Kimberly Vanover, VP, Ph.D
Lawrence Hineline, President, CPA

Stock Performance

Intra Cellular Performance Indicators